Enrolling 17,604 adults aged 45 or older with established cardiovascular disease and a BMI of 27 or higher (without diabetes), SELECT showed that semaglutide 2.4 mg reduced the composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke by 20% over a mean follow-up of nearly 40 months
This can be particularly beneficial for individuals with weakened immune systems, such as those undergoing cancer treatment, dealing with chronic infections, or recovering from illness
Whether it produces meaningfully better outcomes than once-daily dosing in humans remains unknown
doi: 10.1128/jvi.69.6.3584-3596.1995 204 ParB.LehmannM.BeaudinM.NordstrmU.SaikaliS.JulienJ.-P.et al
Therefore, a more easily absorbed and highly stable form of glutathione, S-Acetyl-L-glutathione, can be chosen